Hydroxyurea: An alternative to transfusion therapy for stroke in sickle cell anemia

This publication has 15 references indexed in Scilit:

• Pharmacological modification of hemoglobin F expression in sickle cell anemia: An update on hydroxyurea studies
  Cellular and Molecular Life Sciences, 1993
• High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
  The Journal of Pediatrics, 1991
• Treatment of Sickle Cell Anemia with Hydroxyurea and Erythropoietin
  New England Journal of Medicine, 1990
• Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease
  New England Journal of Medicine, 1988
• Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia
  The Journal of Pediatrics, 1983
• Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents
  The Journal of Pediatrics, 1980
• The natural history of stroke in sickle cell disease
  The American Journal of Medicine, 1978
• Transfusion therapy for cerebrovascular abnormalities in sickle cell disease
  The Journal of Pediatrics, 1976
• A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction
  American Journal of Hematology, 1976
• Occlusion of Large Cerebral Vessels in Sickle-Cell Anemia
  New England Journal of Medicine, 1972